Main > > >DRY EYE SYNDROME. *

Ophthalmo.>Eyelid Cleanser.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.05.




Ophthalmo.>Relief. Nutritional Formula. (U)
Launch Date: 2018. 02.27.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 07.03.




Ophthalmo.>Treat.: Cyclosporin A. (I)
USA Approval Date: 2018. 08.16.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 08.17.




Ophthalmo.>Treat.: Cyclosporin E. (I)
CA Approval Date : ?
USA Approval Date: 2002. 12.23.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 07.02.




Ophthalmo.>Treat.: Cyclosporin S. (D)
AT Launch Year : 2015.
AU Approval Date: 2017. 10.30.
DE Launch Year : 2015.
EU Approval Date: 2013. 07.23.
NZ Launch Date : 2017. 10.30.
(*) Companies; Patent; TradeMark &
Web-Site Available on Request.
UpDate: 2018. 07.02.




Ophthalmo.>Treat.: Lifitegrast
Solution 5%. (U)
CA Approval Date : 2018. 01.03.
USA Approval Date: 2016. 07.11.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 07.03.




Treat.: Teva-Cyclosporine® ophthalmic emulsion, 0.05% w/v. Generic.
CA Launch Date: 2018. 05.10.
(*) Company : Teva Canada Ltd.
UpDate: 2018. 05.11.


>DRY EYE SYNDROME. *'s products
This section has no products